Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation
about
Anti-cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature reviewAssessment of anti-cyclic citrullinated peptide in psoriatic arthritis.Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significanceInflammatory polyarthritis in a patient with psoriasis: is it psoriatic arthritis or rheumatoid arthritis?Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis.Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?Environmental and gene-environment interactions and risk of rheumatoid arthritis.Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis.Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.The IL-23/IL-17 axis in psoriatic arthritis.Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection.Psoriasis in systemic lupus erythematosus: a single-center experience.Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations.Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibodies and C-Reactive Protein in Common Autoimmune Skin Diseases with and without Arthritis.Is osteoporosis an autoimmune mediated disorder?Targeting IL-17 in psoriatic arthritis.Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.Consensus on the management of patients with psoriatic arthritis in a dermatology setting.Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients.
P2860
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
P2860
Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antibodies against cyclic citr ...... or without joint inflammation
@ast
Antibodies against cyclic citr ...... or without joint inflammation
@en
type
label
Antibodies against cyclic citr ...... or without joint inflammation
@ast
Antibodies against cyclic citr ...... or without joint inflammation
@en
prefLabel
Antibodies against cyclic citr ...... or without joint inflammation
@ast
Antibodies against cyclic citr ...... or without joint inflammation
@en
P2860
P356
P1476
Antibodies against cyclic citr ...... or without joint inflammation
@en
P2093
Alenius GM
P2860
P304
P356
10.1136/ARD.2005.040998
P407
P577
2005-08-11T00:00:00Z